MedicalMJ.org - News and Facts About Medical Marijuana

Chronicle AM: NJ Firm Can Drug Test MedMJ Patient, Egypt Bans "Synthetic Hashish," More... (8/17/18)

A federal judge sides with a New Jersey company against a medical marijuana-using worker, Egypt bans "synthetic hashish," a Mexican state advances a bill to decriminalize opium production, and more.

[image:1 align:left caption:true]Medical Marijuana

New Jersey Business Can Drug Test Medical Marijuana Patient, Federal Court Rules. A federal district court judge has ruled that a New Jersey business does not have to waive its requirement for mandatory drug testing to accommodate a worker who uses medical marijuana. The worker had sued the company after it wouldn't allow him to return to work unless he submitted to drug testing. "New Jersey law does not require private employers to waive drug tests for users of medical marijuana," Judge Robert Kugler wrote in his decision. He also noted that "unless expressly provided for by statute, most courts have concluded that the decriminalization of medical marijuana does not shield employees from adverse employment actions."

International

Bolivia President Says He Wants to Return to Coca Farming, But Country Wants Him. President Evo Morales said Thursday he will seek a fourth term in office, citing broad popular support. "The people ask me to return, I do not want to... I want to return to my region to harvest coca, that's the great desire I have, but it is not easy to reject it when the people push you," Morales said. Morales has led the country since 2006, during which period poverty levels have fallen by 3.5%.

Egypt "Synthetic Hashish" Ban. The Health Ministry this week officially banned six forms of "synthetic hashish," or synthetic cannabinoids. The ministry said the ban applied to six "extremely addictive" substances, but it did not provide the technical names for the banned substances.

Mexican State Moving to Legalize Opium Production for Pharmaceutical Purposes. A legislative committee in the state of Guerrero, Mexico's opium production epicenter, has approved a draft bill to decriminalize the production and sale of opium for pharmaceutical purposes. If the bill is approved by the state legislature, it would then be sent to the federal congress for approval. The law is designed to reduce the impact of federal law enforcement on local producers, but critics worry such a law could be used fraudulently by drug cartels supplying heroin to the US.



Chronicle AM: Overdose Deaths at Record High, DEA Cuts Opioid Production Quotas, More... (8/16/18)

Drug overdose deaths hit another record high last year, the DEA is cutting prescription opioid quotas again, California pot tax revenues are not meeting expectations, and more.

[image:1 align:right caption:true]Marijuana Policy

California Pot Tax Revenues Still Sluggish. The state has taken in $82 million in marijuana tax revenues in the first six months of 2018, finance officials reported. That's less than half the $185 million anticipated. Politicians and industry figures say that's because illicit sales still flourish and because many localities in the state don't allow retail marijuana sales. At a meeting with state regulators Tuesday, fingers were also pointed at a shaky supply chain, a shortage of licenses, testing problems and restrictions on retail sales and deliveries.

Medical Marijuana

Utah Medical Marijuana Foes Try Hail Mary Court Challenge to Block Initiative. Opponents of the Proposition 2 medical marijuana initiative filed a lawsuit in state court Wednesday seeking to remove the measure from the ballot. The opponents claim the initiative would tread on their freedom of religion because it violates the religious beliefs of a Mormon foe. "In the United States of America, members of all religions, including the Church of Jesus Christ of Latter Day Saints have a constitutional right to exercise their religious beliefs," the complaint reads. "This includes the right not to consort with, be around, or do business with people engaging in activities which their religion finds repugnant." Proponents of the initiative called the move "a wacky attempt" by foes to derail medical marijuana.

Heroin and Prescription Opioids

DEA Proposes Big Cuts in Opioid Manufacturing Next Year. The DEA has proposed decreasing the manufacturing quotas for the "six most frequently abused" opioids for next by 10%. That would be the third straight year of reductions. The move is described as part of President Trump's Safe Prescribing Plan, which seeks to "cut nationwide opioid prescription fills by one-third within three years." Neither this proposed cut nor the plan address whether bluntly tightening production quotas could lead to shortages for patients needing them for chronic pain.

Overdose Deaths At Record High Last Year, Driven By Opioids. The Centers for Disease Control and Prevention (CDC) reported Wednesday that preliminary figures showed that more than 72,000 Americans died of drug overdoses last year, up 7% over 2016. Opioids, which include prescription painkillers along with heroin and other illegal synthetic opioid drugs, contributed 49,068 to the total number of overdose deaths, the report indicates. From 2002 to 2017, the CDC estimates a 4.1-fold increase in the total number of deaths due to all types of opioid drugs.



This Surprising State Could Be the Next to Legalize Marijuana [FEATURE]

Much attention this year has been focused on marijuana legalization efforts in state legislatures, particularly in the northeast and mid-Atlantic states, but unless Albany and Annapolis and Trenton get their acts together in a hurry, they could be upstaged by a prairie upstart: North Dakota.

[image:1 align:left caption:true]North Dakota Secretary of State Al Jaeger announced Monday that a marijuana legalization initiative sponsored by the grassroots group Legalize ND has qualified for the November ballot. The group had handed in more than 17,000 raw signatures last month and needed 13,452 valid voter signatures to qualify. On Monday, Jaeger reported 14,637 signatures were valid.

"The Legalize ND campaign was able to successfully channel the grassroots enthusiasm for recreational marijuana," said Legalize ND chairman David Owen.

Nine states and the District of Columbia have legalized marijuana since 2012, but all of those states have been in the West or the Northeast. This year, with marijuana legalization on the ballot in Michigan as well as North Dakota, legal weed could make a heartland breakthrough.

The North Dakota initiative has some unique features. Here's what it would and wouldn't do:

  • It would legalize marijuana -- in all its forms -- for people 21 and over by removing marijuana, THC, and hashish from the state's controlled substances schedules.
  • It would provide for the expungement of criminal convictions for anyone convicted of a marijuana-related crime that would be legal under the measure.
  • It does not set any limits on how much marijuana people could possess or how many plants they could grow.
  • It does not create a framework for regulated marijuana sales nor does it set any taxes. Creating a system of taxed and regulated marijuana commerce would be up to the state legislature.

It's only been two years since North Dakota voters approved a medical marijuana initiative, and the state Health Department is still in the process of setting up a system for producing and distributing the drug. That same year, marijuana legalization supporters came up short on signatures to get on the ballot, but they persevered, and here we are.

North Dakota is a deep red state -- Donald Trump got more than twice as many votes as Hillary Clinton in 2016 -- but the only poll done so far has the initiative leading. The June poll, commissioned by Legalize ND and conducted by the Florida-based Kitchen Group, had the initiative winning 46 percent to 39 percent, with 15 percent undecided.

That's good but not great news for Legalize ND. Yes, the initiative is leading, but the conventional wisdom among initiative and referendum watchers is that campaigns should be starting off with at least 60 percent support -- the assumption being that inevitable organized opposition is going to eat away at support levels in the final weeks of the campaign.

And there will be organized opposition. The North Dakota Sheriffs and Deputies Association passed a resolution in May opposing legalization and, now that the initiative has made the ballot, is meeting this week to plot strategy to defeat it.

Association president Pat Rummel, the Billings County sheriff, told the Associated Press this week law enforcement worried about potential problems such as impaired driving, more domestic disputes, and more strain on mental health and addiction treatment facilities.

"We don't have enough facilities to take care of these people," he said. "That's going to be a huge impact, too. Where do we put all these people that need to be into treatment?"

The national anti-legalization group Smart Approaches to Marijuana will also join the effort to defeat the initiative, the group's leader, Kevin Sabet, told the AP. "Our nation is dealing with a five-alarm fire of addiction right now; the last thing we need is more states to throw gasoline on it by promoting more drug use," he said.

That's the tenor of the opposition arguments so far. The question is whether North Dakota voters will still be swayed by such arguments. We'll find out in November.

This article was produced by Drug Reporter, a project of the Independent Media Institute.



Relative Addictive Properties of Various Commonly Used Drugs

relative dangers and addictive properties of various drugs
Source: Dr. Jack E. Henningfield, Ph.D. for NIDA. Reported by: Philip J. Hilts, New York Times, Aug. 2, 1994 "Is Nicotine Addictive? It Depends on Whose Criteria You Use."
Image courtesy of Drug War Facts.

Medical Marijuana News Update

Marijuana is medicine for millions of patients around the US. Click here for medical marijuana news. Federal opposition persists in spite of successful medical marijuana programs in several states. States, cities moving to allow medical use by those in need.

For more information on medical marijuana and other drug policy reform issues, check out the Common Sense for Drug Policy. For the facts about medical marijuana, check out Drug War Facts: Medical Marijuana, and this CSDP public service ad on medical cannabis to learn more.


For The Latest News Check Out:

Common Sense for Drug Policy

Americans For Safe Access

Media Awareness Project

Drug Reform Coordination Network


Support The Campaign!

Support the Coalition campaign! To make a tax-deductible donation click here.


Get Active!

Help make sure that patients can access medical cannabis safely and legally. Americans for Safe Access maintains this terrific Take Action page on their site to help you decide what actions you can take. Common Sense for Drug Policy also maintains this organizers' toolkit on their website.


Meet The Patients

The US Justice Department continues to stand between patients and their medicine. Click here to meet some of the patients and read their stories, and learn why this issue is so important.


The drug war lies on a foundation of myth. Learn the truth. Get the facts. Drug War Facts is your premier information source, offering uptodate information with full citations to aid in further research. Individual sections as well as full edition available electronically at DrugWarFacts.org. Get the facts about medical marijuana, prisons, drug treatment, syringe exchange, and more.
Help spread the word! Put a Drug War Facts banner on YOUR website. Click here for more info.


Marijuana Is Safe, Effective Medicine

Cannabis, or marijuana as it is often called when referring to the drug form of the plant, is an effective medicine that is relatively safer than many commonly-used pharmaceutical products. In the last several decades US doctors and patients have been denied legal access to this substance. Click here to read this well-researched article about the medical benefits of cannabis and learn more about its uses.


Get Informed!

Get the facts about medical cannabis from Drug War Facts.
NORML's website provides a great deal of useful medical cannabis information. California NORML maintains this list of CA medical cannabis resources. Access hundreds of articles on medical cannabis from the popular press.


The US Justice Department is pressing forward with an aggressive campaign to prosecute medical marijuana offenders in spite of California's medical marijuana law (Prop 215) and in defiance of efforts by local officials to support legal medicine for patients. Targets have included prominent medical marijuana patients groups, caregivers, and individual patients attempting to grow medicine for themselves.... Click here for more.


Top Stories On The Web

US PA: A 'Game-Changer' For Pa. Medical Marijuana Flower Goes On Sale

Philadelphia Daily News, 27 Jul 2018 - NEXT WEEK Medical marijuana dispensaries in Pennsylvania are bracing for a surge in new customers when vaporizable "flower" -- the most popular and recognizable form of cannabis -- goes on sale on Wednesday, Aug. 1.

US: Public Faith In Marijuana Outpaces Medical Research, Study Finds

Philadelphia Daily News, 25 Jul 2018 - Despite limited evidence, Americans have an increasingly positive view of the health benefits of marijuana. Nearly two-thirds believe pot can reduce pain, while close to half say it improves symptoms of anxiety, depression, epilepsy, and multiple sclerosis, according to a new online survey of 9,003 adults. Pennsylvania and New Jersey are among the 30 states, along with the District of Columbia, Guam, and Puerto Rico, that have legalized medical marijuana. But scientists say hard data on the health effects of pot -- both positive and negative -- are largely missing. Because marijuana is considered an illicit drug by the federal government, research has been scant, though there are efforts underway in Pennsylvania and nationally to remedy that.

US: Marijuana Bills Increasingly Focus On Social Justice

Philadelphia Daily News, 19 Jul 2018 - State lawmakers and advocates pushing to legalize marijuana this year aren't just touting legalization as a way to raise tax revenue and regulate an underground pot market. They're also talking about fixing a broken criminal justice system and reinvesting in poor and minority communities that have been battered by decades of the government's war on drugs. The focus on justice and equity has sharpened over time, longtime pot advocates say, as it's become clear that such issues should be addressed and that doing so won't alienate voters -- most of whom, polls consistently show, support legal marijuana. Civil rights groups also have raised their voices in legalization discussions.

US PA: Could Marijuana Help Treat Opioid Addiction? Pennsylvania May

Philadelphia Daily News, 06 Jul 2018 - As bad as getting off opioids the first time was, nothing prepared Briana Kline for trying to come back from relapse. She was in deep, past the Percocets and other pills. This time it was heroin, even a close brush with fentanyl. But the medicine that so helped slay her cravings before didn't seem to be cutting it. "The Suboxone didn't make me feel the way it usually does," said Kline, 26, of Lancaster County. "I was struggling a lot with cravings. I'd go a couple of days, be OK. Then I'd go use again."

US FL: Federal Law? State Law? Which Takes Precedence When You Want

Sun-Sentinel, 09 Jul 2018 - WITH CANNABIS? You can't take it with you. Actually, you can. But it's not a good idea when you're traveling, especially for the risk-averse. We speak, of course, of cannabis; its use was approved by 57% of California voters in November 2016. Proposition 64, known as the Adult Use of Marijuana Act, allows the recreational use of marijuana in the Golden State; medical marijuana had been legal for about a decade before that.

US MA: What To Know About Recreational Marijuana Sales In

Hartford Courant, 05 Jul 2018 - July 1, a fated day in Massachusetts for advocates of recreational marijuana, came and went. The first day that stores were allowed to sell nonmedical cannabis passed without so much as a joint sold. No retailers had been licensed, and July 1 turned out much like any other day since December 15, 2016, when it became legal in Massachusetts to possess, grow and give away small quantities of cannabis. But in the intervening year-and-a-half, no retailers have begun selling the drug. Advocates of its recreational use have grown frustrated at the retail rollout's plodding pace.

US CA: Illegal Marijuana Market Still Thrives In Los Angeles

Honolulu Star-Advertiser, 05 Jul 2018 - LOS ANGELES - A slight marijuana smell wafted out as a steady stream of customers walked into a warehouse, its doors and windows covered by bars. Suddenly, police swooped in. "Sheriff's department! Search warrant!" a Los Angeles County deputy shouted as the team thundered through the front door and began hauling out people in handcuffs.

US: Neighbors Flinch At Pot Shops

New York Times, 05 Jul 2018 - Finding a place to house a medical marijuana dispensary is rarely an easy task, but MariMed Advisors, which specializes in developing cannabis businesses, encountered especially aggressive pushback working for a client in Annapolis, Md., last year. The company reviewed several hundred potential locations for the client's proposed dispensary before finally finding one that met nearly every one of the strict requirements demanded by officials of Anne Arundel County. It had the proper zoning classification and the necessary road access. It was not within 1,000 feet of a school. And, as an added plus, the storefront was discreet, located below ground level and behind another building.

US FL: Smokable Medical Pot Case Stays On Hold

Sun-Sentinel, 03 Jul 2018 - TALLAHASSEE -- Chiding a judge who sided with sick patients and saying plaintiffs likely won't win on the merits of the case, an appellate court on Tuesday refused to allow smokable medical marijuana while a legal fight continues to play out. The ruling by a three-judge panel of the 1st District Court of Appeal came in a lawsuit initiated by Orlando trial attorney John Morgan and others who maintain that a Florida law barring patients from smoking their treatment runs afoul of a 2016 constitutional amendment that broadly legalized medical marijuana.

Medical Marijuana

Courtesy of Drug War Facts, a project of Common Sense for Drug Policy.

  1. Since 1996, ten states have legalized medical marijuana use: AK, AZ, CA, CO, HI, ME, NV, OR, VT and WA. Eight of the ten did so through the initiative process, Hawaii's law was enacted by the legislature and signed by the governor in 2000, and Vermont's was enacted by the legislature and passed into law without the governor's signature in May 2004.

    Source:  National Organization for the Reform of Marijuana Laws (NORML), from the web at http://www.norml.org/index.cfm?Group_ID=3391, last accessed Oct. 9, 2004.

  2. The Institute of Medicine's 1999 report on medical marijuana stated, "The accumulated data indicate a potential therapeutic value for cannabinoid drugs, particularly for symptoms such as pain relief, control of nausea and vomiting, and appetite stimulation."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  3. The Institute of Medicine's 1999 report on medical marijuana examined the question whether the medical use of marijuana would lead to an increase of marijuana use in the general population and concluded that, "At this point there are no convincing data to support this concern. The existing data are consistent with the idea that this would not be a problem if the medical use of marijuana were as closely regulated as other medications with abuse potential." The report also noted that, "this question is beyond the issues normally considered for medical uses of drugs, and should not be a factor in evaluating the therapeutic potential of marijuana or cannabinoids."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  4. In the Institute of Medicine's report on medical marijuana, the researchers examined the physiological risks of using marijuana and cautioned, "Marijuana is not a completely benign substance. It is a powerful drug with a variety of effects. However, except for the harms associated with smoking, the adverse effects of marijuana use are within the range of effects tolerated for other medications."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  5. The Institute of Medicine's 1999 report on medical marijuana examined the question of whether marijuana could diminish patients' immune system - an important question when considering marijuana use by AIDS and cancer patients. The report concluded that, "the short-term immunosuppressive effects are not well established but, if they exist, are not likely great enough to preclude a legitimate medical use."

    Source: Janet E. Joy, Stanley J. Watson, Jr., and John A Benson, Jr., "Marijuana and Medicine: Assessing the Science Base," Division of Neuroscience and Behavioral Research, Institute of Medicine (Washington, DC: National Academy Press, 1999).

  6. "Conclusions: Smoked and oral cannabinoids did not seem to be unsafe in people with HIV infection with respect to HIV RNA levels, CD4+ and CD8+ cell counts, or protease inhibitor levels over a 21-day treatment."

    Source:  Abrams, Donald I., MD, et al., "Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection - A Randomized, Placebo-Controlled Clinical Trial," Annals of Internal Medicine, Aug. 19, 2003, Vol. 139, No. 4 (American College of Physicians), p. 258.

  7. "This study provides evidence that short-term use of cannabinoids, either oral or smoked, does not substantially elevate viral load in individuals with HIV infection who are receiving stable antiretroviral regimens containing nelfinavir or indinavir. Upper confidence bounds for all estimated effects of cannabinoids on HIV RNA level from all analyses were no greater than an increase of 0.23 log10 copies/mL compared with placebo. Because this study was randomized and analyses were controlled for all known potential confounders, it is very unlikely that chance imbalance on any known or unknown covariate masked a harmful effect of cannabinoids. Study participants in all groups may have been expected to benefit from the equivalent of directly observed antiretroviral therapy, as well as decreased stress and, for some, improved nutrition over the 25-day inpatient stay."

    Source: Abrams, Donald I., MD, et al., "Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection - A Randomized, Placebo-Controlled Clinical Trial," Annals of Internal Medicine, Aug. 19, 2003, Vol. 139, No. 4 (American College of Physicians), p. 264.

  8. "Nevertheless, when considering all 15 studies (i.e., those that met both strict and more relaxed criteria) we only noted that regular cannabis users performed worse on memory tests, but that the magnitude of the effect was very small. The small magnitude of effect sizes from observations of chronic users of cannabis suggests that cannabis compounds, if found to have therapeutic value, should have a good margin of safety from a neurocognitive standpoint under the more limited conditions of exposure that would likely obtain in a medical setting."

    Source:  Grant, Igor, et al., "Non-Acute (Residual) Neurocognitive Effects Of Cannabis Use: A Meta-Analytic Study," Journal of the International Neuropsychological Society (Cambridge University Press: July 2003), 9, pp. 687-8.

  9. In spite of the established medical value of marijuana, doctors are presently permitted to prescribe cocaine and morphine - but not marijuana.

    Source: The Controlled Substances Act of 1970, 21 U.S.C. 801 et seq.

  10. Organizations that have endorsed medical access to marijuana include: the Institute of Medicine, the American Academy of Family Physicians; American Bar Association; American Public Health Association; American Society of Addiction Medicine; AIDS Action Council; British Medical Association; California Academy of Family Physicians; California Legislative Council for Older Americans; California Medical Association; California Nurses Association; California Pharmacists Association; California Society of Addiction Medicine; California-Pacific Annual Conference of the United Methodist Church; Colorado Nurses Association; Consumer Reports Magazine; Kaiser Permanente; Lymphoma Foundation of America; Multiple Sclerosis California Action Network; National Association of Attorneys General; National Association of People with AIDS; National Nurses Society on Addictions; New Mexico Nurses Association; New York State Nurses Association; New England Journal of Medicine; and Virginia Nurses Association.

  11. A few of the editorial boards that have endorsed medical access to marijuana include: Boston Globe; Chicago Tribune; Miami Herald; New York Times; Orange County Register; and USA Today.

  12. Many organizations have favorable positions (e.g., unimpeded research) on medical marijuana. These groups include: The Institute of Medicine, The American Cancer Society; American Medical Association; Australian Commonwealth Department of Human Services and Health; California Medical Association; Federation of American Scientists; Florida Medical Association; and the National Academy of Sciences.

  13. The Controlled Substances Act of 1970 established five categories, or "schedules," into which all illicit and prescription drugs were placed. Marijuana was placed in Schedule I, which defines the substance as having a high potential for abuse, no currently accepted medical use in the United States, and a lack of accepted safety for use under medical supervision. To contrast, over 90 published reports and studies have shown marijuana has medical efficacy.

    Source: The Controlled Substances Act of 1970, 21 U.S.C. 801 et seq.; Common Sense for Drug Policy, Compendium of Reports, Research and Articles Demonstrating the Effectiveness of Medical Marijuana, Vol. I & Vol. II (Falls Church, VA: Common Sense for Drug Policy, March 1997).

  14. The U.S. Penal Code states that any person can be imprisoned for up to one year for possession of one marijuana cigarette and imprisoned for up to five years for growing a single marijuana plant.

    Source: The Controlled Substances Act of 1970, 21 U.S.C. 801 et seq.

  15. On September 6, 1988, the Drug Enforcement Administration's Chief Administrative Law Judge, Francis L. Young, ruled:
    "Marijuana, in its natural form, is one of the safest therapeutically active substances known....[T]he provisions of the [Controlled Substances] Act permit and require the transfer of marijuana from Schedule I to Schedule II. It would be unreasonable, arbitrary and capricious for the DEA to continue to stand between those sufferers and the benefits of this substance."

    Source: US Department of Justice, Drug Enforcement Agency, "In the Matter of Marijuana Rescheduling Petition," [Docket #86-22] (September 6, 1988), p. 57.

  16. The DEA's Administrative Law Judge, Francis Young concluded: "In strict medical terms marijuana is far safer than many foods we commonly consume. For example, eating 10 raw potatoes can result in a toxic response. By comparison, it is physically impossible to eat enough marijuana to induce death. Marijuana in its natural form is one of the safest therapeutically active substances known to man. By any measure of rational analysis marijuana can be safely used within the supervised routine of medical care."

    Source: US Department of Justice, Drug Enforcement Agency, "In the Matter of Marijuana Rescheduling Petition," [Docket #86-22], (September 6, 1988), p. 57.

  17. Between 1978 and 1997, 35 states and the District of Columbia passed legislation recognizing marijuana's medicinal value.
    States include: AL, AZ, AR, CA, CO, CT, FL, GA, IL, IA, LA, MA, ME, MI, MN, MO, MT, NV, NH, NJ, NM, NY, NC, OH, OK, OR, RI, SC, TN, TX, VT, VA, WA, WV, and WI.

For additional research on medical marijuana, see this excellent analysis of medical marijuana research by Common Sense for Drug Policy President Kevin B. Zeese and this update from Common Sense for Drug Policy, as well as the Drug War Facts section on marijuana.

copyright © 2003-2010, Coalition for Medical Marijuana
Sponsors Include: American Alliance for Medical Cannabis   --   Americans for Safe Access   --   Angel Justice   --   Angel Wings Patient OutReach, Inc.   --   California NORML   --   CannabisMD   --   Cannabis Action Network   --   Cannabis Consumers Campaign   --   Change The Climate   --   Common Sense for Drug Policy   --   DRCNet   --   Drug Policy Alliance   --   DrugSense   --   Green Aid   --   Human Rights in the Drug War   --   Patients Out of Time   --   Rhode Island Patient Advocacy Coalition   --   Safe Access
info@csdp.org